You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY22 is not expected to be complete until September, 2023.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
-
EPICERTIN for Mucosal Healing in Ulcerative Colitis
SBC: Grow Biomedicine LLC Topic: 300Project Summary We have developed a candidate product that induces colon epithelial repair in ulcerative colitis (UC) models. UC comprises a major type of inflammatory bowel disease and is characterized by chronic and relapsing inflammation in the gastrointestinal (GI) tract. UC develops in the innermost mucosal layer of the distal GI tract in a continuous manner, usually starting at the rectum an ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Development of a novel, non-hormonal female contraceptive device
SBC: VENOVA TECHNOLOGIES, INC. Topic: NICHDPROJECT SUMMARY The applicant, Venova Technologies, is a woman-led medical device startup company. Venova Technologies is applying for a Small Business Technology Transfer (STTR) Phase I grant to fund development towards technical milestones that will advance the commercial potential of our patent-pending non-hormonal contraceptive device. Half of pregnancies in the United States are unintended du ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
FASTT telehealth behavioral support service for caregivers of children with developmental delay or disability
SBC: Special X, Inc Topic: NICHDProject Abstract Over 7 million children in the U.S. receive support for a developmental delay or disability (DD). For caregivers of these children, behavior issues that often accompany their childandapos;s condition create high levels of stress leading to increased mental and physical health issues and impacts on caregiver-child interactions and family functioning. Although evidence-based practic ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Development and Pre-Clinical Testing of Antimicrobial PEKK/Silicon Nitride Trauma Plates with Carbon Fiber Reinforcement
SBC: SINTX TECHNOLOGIES, INC. Topic: NIAMSPROJECT SUMMARY—More than 2 million Americans are hospitalized each year with bone fractures, and many more undergo outpatient procedures for fracture reduction and fixation. Some injuries can be treated with closed reduction and splinting or casting to immobilize the bone during healing. However, at some sites, more than half of fractures require open reduction and internal fixation. Despite ad ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Bounding generalization risk for Deep Neural Networks
SBC: Euler Scientific Topic: NGA20A001Deep Convolutional Neural Networks (DCNNs) have become ubiquitous in the analysis of large datasets with geometric symmetries. These datasets are common in medicine, science, intelligence, autonomous driving and industry. While analysis based on DCNNs have proven powerful, uncertainty estimation for such analyses has required sophisticated empirical studies. This has negatively impacted the effect ...
STTR Phase II 2022 Department of DefenseNational Geospatial-Intelligence Agency -
A novel clot containing system for improved neurothrombectomy outcomes
SBC: XTRACT MEDICAL INC Topic: 106PROJECT SUMMARY Mechanical thrombectomy (MT) has recently gained impetus as a treatment for acute ischemic stroke (AIS). Although technical progress has been made, the efficacy of the current techniques remains sub-optimal and MT is still associated with significant complications. Current MT techniques, using stent retrievers or aspiration catheters, achieve successful revascularization after the ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Broadly Accessible Technologies for Single-cell Joint Analysis of Transcriptome and Epigenome
SBC: EPIGENOME TECHNOLOGIES, INC Topic: 101AbstractHistone modifications carry rich information of cellular memory and gene regulatory mechanisms. Single cell analysis of histone modification in conjunction with transcriptome could recover this critical layer of cell identity and help to dissect the cellular and molecular composition of complex tissues such as the brain. We recently developed an ultra-high throughput single cell multi-omic ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Nanoimmunotherapy for chronic immune-mediated diseases
SBC: GENERAL NANOTHERAPEUTICS LLC Topic: NIAIDABSTRACT Current pharmaceutical agents that are used for the treatment of immune-mediated inflammatory conditions including autoimmune diseases generally do not lead to remission and frequently carry toxic side effects. Here we propose a strategy that can harness the capacity of the immune system to induce immunoregulatory response that can suppress immune hyperactivity and chronic inflammation in ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
Development of the UValidate platform for the profiling of topically applied chemical agents.
SBC: AMELIA TECHNOLOGIES LLC Topic: NIEHSProject Summary Skin is the first line of defense against the outside environment. When the skin barrier is breached by UV irradiation (UVR) or toxic chemicals, living cell layers including epidermal keratinocytes, melanocytes and dermal fibroblasts are subjected to DNA damage. If unrepaired, this damage can lead to photoaging and cutaneous carcinogenesis. In fact, skin cancer is by far the most c ...
STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health -
Opioid Indicator Spray for Complex Surfaces
SBC: Clear Scientific, LLC Topic: CBD20AT001Opioids, especially synthetic opioids, are a constant threat to the safety of civilian first responders; there are now serious concerns about their use in modern chemical warfare. Fentanyl and its many analogues (carfentanil, remifentanil, lofentanil, mefentanil, sufentanil, etc.) are extremely hazardous—if ingested or inhaled, many synthetic opioids cause lethal intoxication with only a few gra ...
STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense